• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌筛查中常用的选择标准在不同国家可能具有差异很大的诊断性能。

Commonly Applied Selection Criteria for Lung Cancer Screening May Have Strongly Varying Diagnostic Performance in Different Countries.

作者信息

Brenner Hermann, Krilaviciute Agne

机构信息

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.

出版信息

Cancers (Basel). 2020 Oct 16;12(10):3012. doi: 10.3390/cancers12103012.

DOI:10.3390/cancers12103012
PMID:33081402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7602978/
Abstract

Lung cancer (LC) screening often focuses heavy smokers as a target for screening group. Heavy smoking can thus be regarded as an LC pre-screening test with sensitivities and specificities being different in various populations due to the differences in smoking histories. We derive here expected sensitivities and specificities of various criteria to preselect individuals for LC screening in 27 European countries with diverse smoking prevalences. Sensitivities of various heavy-smoking-based pre-screening criteria were estimated by combining sex-specific proportions of people meeting these criteria in the target population for screening with associations of heavy smoking with LC risk. Expected specificities were approximated by the proportion of individuals not meeting the heavy smoking definition. Estimated sensitivities and specificities varied widely across countries, with sensitivities being generally higher among men (range: 33-80%) than among women (range: 9-79%), and specificities being generally lower among men (range: 48-90%) than among women (range: 70-99%). Major variation in sensitivities and specificities was also seen across different pre-selection criteria for LC screening within individual countries. Our results may inform the design of LC screening programs in European countries and serve as benchmarks for novel alternative or complementary tests for selecting people at high risk for CT-based LC screening.

摘要

肺癌(LC)筛查通常将重度吸烟者作为筛查对象。因此,重度吸烟可被视为一种肺癌预筛查测试,由于吸烟史不同,其在不同人群中的敏感度和特异度也有所差异。我们在此得出了在27个吸烟率各异的欧洲国家中,用于肺癌筛查预选择个体的各种标准的预期敏感度和特异度。通过将目标筛查人群中符合这些标准的特定性别人口比例与重度吸烟与肺癌风险的关联相结合,估算了各种基于重度吸烟的预筛查标准的敏感度。预期特异度通过未符合重度吸烟定义的个体比例来近似。各国的估算敏感度和特异度差异很大,男性的敏感度普遍高于女性(范围:33%-80%),女性为(范围:9%-79%);男性的特异度普遍低于女性(范围:48%-90%),女性为(范围:70%-99%)。在各个国家内,不同的肺癌筛查预选择标准之间的敏感度和特异度也存在显著差异。我们的结果可为欧洲国家肺癌筛查项目的设计提供参考,并作为基于CT的肺癌筛查高危人群选择的新型替代或补充测试的基准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccb2/7602978/16d683a426b6/cancers-12-03012-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccb2/7602978/ebf868bc7a3e/cancers-12-03012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccb2/7602978/8e05efba2a6d/cancers-12-03012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccb2/7602978/16d683a426b6/cancers-12-03012-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccb2/7602978/ebf868bc7a3e/cancers-12-03012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccb2/7602978/8e05efba2a6d/cancers-12-03012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccb2/7602978/16d683a426b6/cancers-12-03012-g003.jpg

相似文献

1
Commonly Applied Selection Criteria for Lung Cancer Screening May Have Strongly Varying Diagnostic Performance in Different Countries.肺癌筛查中常用的选择标准在不同国家可能具有差异很大的诊断性能。
Cancers (Basel). 2020 Oct 16;12(10):3012. doi: 10.3390/cancers12103012.
2
3
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.用于选择肺癌筛查候选者的风险预测模型:一项回顾性验证研究。
PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr.
4
5
Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.识别肺癌筛查高危个体:超越 NLST 标准。
PLoS One. 2018 Apr 5;13(4):e0195441. doi: 10.1371/journal.pone.0195441. eCollection 2018.
6
Improving selection criteria for lung cancer screening. The potential role of emphysema.改善肺癌筛查的选择标准。肺气肿的潜在作用。
Am J Respir Crit Care Med. 2015 Apr 15;191(8):924-31. doi: 10.1164/rccm.201410-1848OC.
7
Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.9 种用于结直肠癌筛查的定量粪便免疫化学检测方法的诊断性能直接比较。
Gastroenterology. 2018 Jan;154(1):93-104. doi: 10.1053/j.gastro.2017.09.018. Epub 2017 Sep 25.
8
Occupation and cancer - follow-up of 15 million people in five Nordic countries.职业与癌症 - 五个北欧国家的 1500 万人随访研究。
Acta Oncol. 2009;48(5):646-790. doi: 10.1080/02841860902913546.
9
Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.九种风险预测模型对选择持续吸烟者进行计算机断层扫描肺癌筛查的影响。
Ann Intern Med. 2018 Jul 3;169(1):10-19. doi: 10.7326/M17-2701. Epub 2018 May 15.
10
Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.风险预测模型与简化选择标准在确定肺癌筛查资格中的比较:基于德国联邦范围调查和发病数据的分析。
Eur J Epidemiol. 2020 Oct;35(10):899-912. doi: 10.1007/s10654-020-00657-w. Epub 2020 Jun 27.

引用本文的文献

1
Identifying the population to be targeted in a lung cancer screening programme in Denmark.确定丹麦肺癌筛查计划中的目标人群。
BMJ Open Respir Res. 2024 Dec 25;11(1):e002499. doi: 10.1136/bmjresp-2024-002499.
2
Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patients.比较不同标准对德国患者队列中筛查肺癌患者的敏感性。
Cancer Med. 2023 Apr;12(7):8880-8896. doi: 10.1002/cam4.5638. Epub 2023 Jan 27.
3
New Implications of Patients' Sex in Today's Lung Cancer Management.

本文引用的文献

1
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.随机试验中 CT 容积筛查降低肺癌死亡率
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
2
A combined panel of circulating microRNA as a diagnostic tool for detection of the non-small cell lung cancer.联合循环 microRNA panel 作为非小细胞肺癌检测的诊断工具。
QJM. 2019 Oct 1;112(10):779-785. doi: 10.1093/qjmed/hcz158.
3
Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
患者性别在当今肺癌治疗中的新意义
Cancers (Basel). 2022 Jul 13;14(14):3399. doi: 10.3390/cancers14143399.
低剂量计算机断层扫描(LDCT)筛查降低肺癌死亡率-来自德国 LUSI 随机试验的结果。
Int J Cancer. 2020 Mar 15;146(6):1503-1513. doi: 10.1002/ijc.32486. Epub 2019 Jun 20.
4
A volatile biomarker in breath predicts lung cancer and pulmonary nodules.呼气中的挥发性生物标志物可预测肺癌和肺结节。
J Breath Res. 2019 Jun 19;13(3):036013. doi: 10.1088/1752-7163/ab21aa.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Lung cancer screening with low-dose CT: a world-wide view.低剂量CT肺癌筛查:全球视角
Transl Lung Cancer Res. 2018 Jun;7(3):234-242. doi: 10.21037/tlcr.2018.05.12.
7
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年(CONCORD-3):对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.
8
Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.采用下一代测序技术评估肿瘤来源外泌体 miRNA 作为早期非小细胞肺癌潜在诊断生物标志物。
Clin Cancer Res. 2017 Sep 1;23(17):5311-5319. doi: 10.1158/1078-0432.CCR-17-0577. Epub 2017 Jun 12.
9
Detection of lung cancer in exhaled breath with an electronic nose using support vector machine analysis.利用支持向量机分析的电子鼻检测呼出气中的肺癌
J Breath Res. 2017 Aug 21;11(3):036009. doi: 10.1088/1752-7163/aa7799.
10
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.ITALUNG 随机肺癌筛查试验中的死亡率、生存率和发病率。
Thorax. 2017 Sep;72(9):825-831. doi: 10.1136/thoraxjnl-2016-209825. Epub 2017 Apr 4.